LM22A-4

CAS : 37988-18-4

Ref. 3D-MBA98818

Informations sur le produit

• Nom: LM22A-4
• Synonymes: N1,N3,N5-Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide, LM 22A4, N,N′,N′′-Tris(β-hydroxyethyl)trimesamide, 1,3,5-Benzenetricarboxamide, N,N′,N′′-tris(2-hydroxyethyl)-, 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(2-hydroxyethyl)-

Description

LM22A-4 is a monoclonal antibody that binds to the neurotrophic factor nerve growth factor (NGF) and prevents it from activating its receptor. LM22A-4 has been shown to have neuroprotective effects in vivo, and can be used to treat neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, LM22A-4 has been shown to promote neuronal function by increasing energy metabolism and mitochondrial biogenesis in vitro. The molecule also has immunomodulatory properties that may help with inflammatory conditions such as arthritis or asthma.
LM22A-4 is an antibody that was generated from a mouse immunized with human NGF. It binds to the natural compound NGF and prevents it from activating its receptor. LM22A-4 has been shown to have neuroprotective effects in vivo, and can be used to treat neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 339.34 g/mol
• Formule: C₁₅H₂₁N₃O₆
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder